Pain, Neurological Disorders, and Cerebrovascular Pathophysiology: Study Notes for Anatomy & Physiology

Pain: Pathways, Perception, and Types

Role and Definition of Pain

Pain serves as a critical biological signal, motivating individuals to seek medical attention and adopt behaviors that promote healing. It is both a sensory and emotional experience, often acting as a conditioning stimulus to prevent further injury.

• Definition: Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage (International Association for the Study of Pain).

• Role:

  • Motivates help-seeking for medical problems

  • Encourages healing behaviors

  • Acts as a conditioning stimulus to avoid further damage

Pain vs. Nociception

Pain and nociception are related but distinct concepts in neurophysiology.

Nociception	Pain
Third-person perspective	First-person perspective
Stimulus-related	Perception-related
Sensory discrimination	Suffering

• Nociception: The neural processes of encoding and processing noxious stimuli.

• Pain: The conscious perception and emotional response to nociceptive signals.

Pain Terminology

Understanding pain requires familiarity with key terms describing its duration, cause, and response.

Term	Definition
Acute pain	Pain that lasts less than 3 months.
Allodynia	Pain due to a stimulus that does not normally provoke pain.
Analgesia	Absence of pain in response to a stimulus that would normally be painful.
Chronic pain	Pain that lasts longer than 3 months.
Hyperalgesia	An increased response to a stimulus that is normally painful.
Referred pain	Pain perceived as occurring in a region of the body topographically distinct from the region in which the source of pain is located.

Types of Pain

Pain can be classified based on its origin and underlying mechanisms.

• Nociceptive pain: Results from actual or threatened damage to non-neural tissue, typically due to activation of nociceptors. Examples include pain from cuts, burns, or inflammation.

• Neuropathic pain: Caused by injury or disease affecting the nervous system, such as diabetic neuropathy or post-herpetic neuralgia.

• Psychogenic pain: Pain influenced by psychological factors, often without clear physical cause.

Classification by Duration and Response

Type	Features
Acute	Short duration, resolves with healing, responds to reasonable doses of analgesics, aids rehabilitation, mostly nociceptive in origin.
Chronic (non-cancer)	Persists for months beyond healing, poor response to conventional analgesics, associated with neuropathic features.
Cancer	May persist for months, responds to many interventions, may have mixed nociceptive and neuropathic features.

Pathways and Physiology of Pain

Nociception Pathways

Pain perception involves complex neural pathways from peripheral receptors to the brain.

• Receptor level: Nociceptors detect mechanical, chemical, or thermal stimuli.

• Spinal cord: Transmission via spinothalamic tract neurons.

• Thalamocortical neurons: Relay signals to the cortex for conscious perception.

• Cortical representation: Sensory-discriminative and affective-motivational components processed in different brain regions.

Types of Nociceptors

• High threshold mechanoreceptors: Activated by intense mechanical stimuli, transmit sharp pain via myelinated fibers.

• Polymodal nociceptors: Respond to mechanical, chemical, and thermal stimuli, transmit dull, aching, or burning pain via unmyelinated fibers.

• Musculoskeletal and visceral nociceptors: Often stimulate unmyelinated nerves, associated with deep, aching pain.

Neuromodulation of Pain

Pain signals are modulated by various neurotransmitters and neuromodulators in the nervous system.

• Excitatory neuromodulators: Substance P, glutamate, somatostatin (increase pain transmission).

• Inhibitory neuromodulators: GABA, glycine, serotonin, noradrenaline, endorphins (decrease pain transmission).

• Endorphins: Endogenous opioids such as beta-endorphins and enkephalins bind to opioid receptors to reduce pain.

Clinical Manifestations and Assessment of Pain

• Pain tolerance: The maximum intensity or duration of pain a person can endure before seeking relief.

• Pain threshold: The point at which a stimulus is perceived as painful.

• Pain dominance: Physiological responses such as tachycardia, tachypnoea, increased blood pressure, sweating, nausea, and vomiting.

Pain assessment (PQRSTU): A systematic approach to evaluating pain:

• P: Provocation/Palliation (What causes or relieves the pain?)

• Q: Quality (What does the pain feel like?)

• R: Region/Radiation (Where is the pain? Does it spread?)

• S: Severity (How severe is the pain?)

• T: Timing (When did it start? How long does it last?)

• U: Understanding (What does the patient think is causing the pain?)

Treatment of Pain

• Mild pain: Paracetamol, non-opioid analgesics, adjuvants.

• Moderate pain: Opioids (e.g., codeine, tramadol), non-opioids, adjuvants.

• Severe pain: Strong opioids (e.g., morphine, fentanyl, methadone), adjuvants.

• Advance up the analgesic ladder if pain persists.

Pathophysiology of Pain

Peripheral Neuropathic Pain

• Mononeuropathy: Damage to a single peripheral nerve.

• Polyneuropathy: Damage to multiple peripheral nerves.

• Complex regional pain syndromes: Chronic pain following injury, often with autonomic and trophic changes.

• Painful diabetic neuropathy: Nerve damage due to diabetes.

• Post-herpetic neuralgia: Persistent pain after shingles.

Central Pain Syndromes

• Result from damage to brain or spinal cord sites that process pain.

Degenerative Disorders of the Nervous System

Parkinson's Disease

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra of the basal nuclei.

• Typical onset: After age 40; average diagnosis at 55-65 years; more common in males.

• Manifestations:

  • Tremor at rest

  • Rigidity and bradykinesia (slowness of movement)

  • Postural disturbance

  • Difficulty speaking and swallowing

  • Parkinsonism: tremor, rigidity, bradykinesia

  • Loss of postural reflexes, falls

  • Mask-like face, monotone speech

  • Autonomic dysfunction: excess sweating, salivation, orthostatic hypotension, constipation, impotence, poor temperature control

  • Cognitive dysfunction

Diagnosis and Treatment:

• Diagnosis: History, examination, SPECT imaging

• Pharmacological: Dopamine agonists (levodopa)

• Non-pharmacological: Group support, education, exercise, nutrition

• Botulinum toxin injections for dystonias

• Surgical: Lesions in brainstem, deep brain stimulation (electrodes in subthalamic nucleus or globus pallidus)

• Experimental: Gene therapy, stem cells

Multiple Sclerosis (MS)

Multiple sclerosis is a progressive, inflammatory, autoimmune demyelinating disorder of the central nervous system (CNS).

• Pathophysiology: Destruction of oligodendrocytes (myelin-forming cells) by T cells.

• Course: Relapses and remissions; progressive loss of function leads to permanent disability after 20+ years.

• First signs: Paresthesias, optic disturbances, abnormal sensations in extremities and face.

Symptoms of Multiple Sclerosis

Symptom
Loss of coordination/clumsiness
Speech difficulties
Hand shaking/tremor
Loss of bladder/bowel control
Extreme fatigue
Sight impairments
Memory lapses
Vertigo
Weakness
Impaired sensation

Diagnosis and Treatment:

• Diagnosis: Clinical and laboratory criteria (CSF analysis, MRI, visual evoked potential)

• Management: Interferon, corticosteroids, antidepressants, other drugs

• Supportive care: Assistance with activities of daily living (ADLs)

Intracranial Pressure and Cerebrovascular Disorders

Monro-Kellie Hypothesis

The Monro-Kellie hypothesis states that the cranial vault is a fixed volume composed of blood, brain tissue, and cerebrospinal fluid (CSF). An increase in one component must be offset by a decrease in another to maintain normal intracranial pressure (ICP).

• Normal ICP: 5 to 15 mmHg

Increased Intracranial Pressure (ICP)

• Ischaemia results from reduced or interrupted blood flow, leading to neurological deficits.

Cerebrovascular Accidents (CVAs)

Cerebrovascular accidents, or strokes, are caused by interruption of cerebral blood flow.

• Thrombotic stroke: Arterial occlusions from thrombi formed in arteries supplying the brain or intracranial vessels.

• Transient ischaemic attacks (TIAs): Brief episodes of neurological dysfunction due to temporary cerebral ischaemia.

• Lacunar infarcts: Small vessel strokes.

• Embolic stroke: Fragments from a thrombus formed outside the brain travel to cerebral vessels.

• Haemorrhagic stroke: Bleeding within the brain (intracerebral) or in the subarachnoid space.

Evaluation and Treatment of Stroke

• Evaluation: Patient history, CT scan, MRI, angiography, lumbar puncture, ABCD system for TIAs

• Supportive care: Maintain cerebral perfusion

• Thrombotic stroke: Thrombolysis

• Haemorrhagic stroke: Treat raised ICP, stop bleeding

Manifestations and Ongoing Treatment

• Anticoagulants (warfarin, aspirin) to prevent further ischaemic stroke

• Removal of risk factors: Lower BP, control atrial fibrillation, stop smoking, control diabetes and lipids

• Early and aggressive rehabilitation

Risk Factors for Stroke

• Increasing age, sex, race, family history

• Hypertension, smoking

• Poorly controlled diabetes (accelerated atherosclerosis)

• Carotid stenosis

• Sickle cell disease

• Hyperlipidaemia

• Atrial fibrillation

Additional info: Academic context and definitions have been expanded for clarity and completeness. Tables have been recreated and some entries inferred for self-contained study notes.